Caption Management, LLC Affimed N.V. Call Options Transaction History

Caption Management, LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q4 2021 Feb 11, 2022	SELL	$5.37 - $7.07 $1.07 Million - $1.41 Million	-200,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$5.54 - $7.51 $1.11 Million - $1.5 Million	200,000 New	200,000 $1.24 Million

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $185M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.